Gene Therapy Prospects for Duchenne Muscular Dystrophy

Publisher Website
Google Scholar
Abstract
Duchenne muscular dystrophy (DMD) is a devastating neuromuscular disorder caused by mutations in the dystrophin gene. The lack of adequate therapy for this disease provides impetus for the development of gene therapy strategies. A recombinant dystrophin cDNA and animal models of the disease are available for this therapy development. Characterization of these reagents and current progress toward gene therapy for DMD will be described.

This publication has 0 references indexed in Scilit: